Clinical Trial Update: Denosumab vs Zoledronate After Lumbar Fusion [Phase 3]

View source ↗

Summary

Phase 3 trial comparing denosumab to zoledronate after lumbar fusion for patients with osteopenia and lumbar spondylolisthesis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Spondylolisthesis
• Osteopenia

Drugs mentioned

• Denosumab (denosumab)
• Zoledronate (zoledronic acid)

Snippet

Sponsor: Shenzhen People's Hospital | Conditions: Osteopenia, Lumbar Spondylolisthesis | Phase 3 | Status: UNKNOWN